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Abstract We demonstrated that adrenomedullin (AM) is
produced and secreted from human leukemia cell lines (THP-1
and HL-60) as well as peripheral blood granulocytes, lympho-
cytes, monocytes and monocyte-derived macrophages. Immuno-
reactive AM accumulated in the culture media of THP-1 and
HL-60 cells increased according to their differentiation into
macrophage-like cells. Retinoic acid exerted synergistic effects
on AM secretion from THP-1 and HL-60 cells when adminis-
tered with tumor necrosis factor-K, lipopolysaccharide or 12-O-
tetradecanoyl phorbol-13-acetate. AM was shown to increase the
scavenger receptor activity on THP-1 cells. Thus, monocytes/
macrophages should be recognized as sources of AM, and the
secreted AM may modulate the function of macrophages.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Adrenomedullin (AM) is a potent vasorelaxant peptide
originally isolated from extracts of human pheochromocyto-
ma [1]. We have shown that cultured endothelial cells (ECs)
and vascular smooth muscle cells (VSMCs) actively produce
and secrete AM into culture medium, and its production is
augmented by interleukin-1 (IL-1), tumor necrosis factor-K
(TNF-K) and lipopolysaccharide (LPS) [2^5]. In an in vivo
study, intravenous administration of LPS into rats elevated
plasma AM concentration 20-fold and augmented AM gene
expression in almost all tissues including blood vessels, lung
and intestine [6]. The plasma AM levels in patients with septic
shock also increased markedly compared with those in healthy
volunteers [7]. These data suggest the possibility that AM
contributes to the induction of refractory hypotension in sep-
tic shock.
On the other hand, monocytes/macrophages are activated
by exposure to foreign bodies such as LPS, and then start to
synthesize and secrete various cytokines, including IL-1 and
TNF-K. These data suggest that monocytes/macrophages are
another candidate for AM secreting cells in sepsis. To assess
this possibility, the human monocytic cell line THP-1 was
studied, since it is a highly di¡erentiated monocytic cell line
and expresses macrophage-like characteristics after stimula-
tion with phorbol esters [8,9]. In addition, we examined a
human myeloid leukemic cell line, HL-60, which can di¡er-
entiate into macrophages and granulocytes by stimulation
with phorbol ester and retinoic acid (RA), respectively
[10,11]. In this study, we report that AM is produced and
secreted from these cultured human leukemia cell lines after
their di¡erentiation as well as from peripheral blood mono-
cytes and monocyte-derived macrophages.
2. Materials and methods
2.1. Materials
Human AM (40^52) and its N-Tyr derivative were synthesized on a
peptide synthesizer 431A (Applied Biosystems). The following materi-
als were used: human interferon-Q (IFN-Q) (Pepro Tec Inc.), human
recombinant IL-1L and TNF-K (RpD Systems), dexamethasone, 12-
O-tetradecanoyl phorbol-13-acetate (TPA) (Wako Pure Chemicals),
Escherichia coli LPS (serotype O26:B6) (Parsel+Lorei) and all-trans
RA (Sigma). Acetylated low density lipoprotein labeled with 1,1P-dio-
ctadecyl-3,3,3P,3P-tetramethylindo-carbocyanine perchorate (DiI-
acLDL) was purchased from Biomedical Technologies. Dulbecco’s
modi¢ed Eagle’s medium (DMEM) was purchased from Nikken Bio-
Medical Laboratory. TPA and dexamethasone were ¢rst dissolved in
ethanol, RA dissolved in dimethylsulfoxide, and then diluted with an
incubation medium, DMEM containing 0.1% bovine serum albumin
(BSA). LPS was dissolved in 0.9% NaCl solution and diluted with the
incubation medium. The other substances were dissolved according to
the producers’ manuals and diluted with the incubation medium.
2.2. Cell culture
THP-1 and HL-60 cells were obtained from American Type Culture
Collection and cultured in RPMI 1640 medium (Gibco) containing
10% fetal calf serum (FCS) at 37‡C in a humidi¢ed atmosphere con-
taining 5% CO2.
2.3. Preparation of conditioned medium
THP-1 and HL-60 cells, grown for 4^5 days in 10 cm dishes (ap-
proximately 1U107 cells/dish), were washed twice with DMEM, and
then 10 ml of DMEM containing 0.1% BSA and stimulants were
added and incubated for 40 h at 37‡C. To measure AM secretion
from fully di¡erentiated THP-1 cells, the cells were ¢rst incubated
with TPA (10ÿ8 M) for 3 days. Then, the di¡erentiated cells were
incubated for another 40 h after replacing the media. After incuba-
tion, acetic acid and Triton X-100 were added to the culture media
(¢nal concentration: 0.5 M and 0.002%), and the resulting solutions
were heated at 100‡C for 10 min to inactivate proteases. The incubates
were extracted with pre-washed Sep-Pak C18 cartridges (Millipore
Corp., Waters Division) as reported previously [6], since the levels
of immunoreactive (IR) AM in the medium were too low to measure
directly. The absorbed material was eluted with 60% acetonitrile in
0.1% tri£uoroacetic acid and lyophilized. The lyophilisates were dis-
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solved in a radioimmunoassay (RIA) bu¡er and submitted to RIAs
for AM. Intracellular IR-AM contents were measured after extraction
and concentration [2]. The viability of THP-1 and HL-60 cells after 40
h incubation was more than 90% by trypan blue staining.
2.4. RIAs for AM
Details of preparation and characterization of antiserum #172CI-7
against human AM (40^52), which can also recognize the whole mol-
ecule of AM at the same a⁄nity, have been reported by Sakata et al.
[12]. Monoiodinated N-Tyr-AM (40^52) isolated by reverse phase
HPLC was used as a tracer [2].
2.5. MO-1 antigen expression and DiI-acLDL uptake
After washing three times with cold phosphate-bu¡ered saline
(PBS), THP-1 and HL-60 cells were labeled for 10 min at room
temperature with £uorescein isothiocyanate (FITC)-labeled MO-1
(CD11b) antibody (Coulter Immunology) or FITC-labeled IgM (Bio
Source) as control. DiI-acLDL was added to the culture medium of
RPMI 1640 at a ¢nal concentration of 5 Wg/ml, 5 h before collection
of cells. The cells were collected, washed twice with cold PBS, and
stored in 0.05% paraformaldehyde in saline at 4‡C until £ow cyto-
metric analysis. Labeled cells were analyzed on a £ow cytometer, Cyto
ACE-150 (JASCO Corp.), equipped with an argon laser at 488 nm.
2.6. Isolation of peripheral blood granulocytes, lymphocytes, monocytes
and monocyte-derived macrophages
Peripheral blood mononuclear cells and polymorphonuclear cells
were isolated from heparinized venous blood of healthy volunteers
using a standard Ficoll/metrizoate gradient (Mono-Poly resolving me-
dium, Dainippon Laboratory Products), and then washed with PBS.
The mononuclear leukocyte fraction was resuspended in PBS and
seeded on monocyte separating plates (MSP) (Japan Immunoresearch
Laboratories Co.) at a concentration of 2U107 cells/plate. After 1 h
incubation to allow for adherence of monocytes, the plates were
washed to remove non-adherent cells. The non-adherent cells (lym-
phocytes) were resuspended in a RPMI medium supplemented with
10% FCS and incubated at 37‡C in a CO2 incubator for 40 h with or
without LPS (100 ng/ml). Monocytes (adherent cells) were stripped
with 0.02% EDTA and resuspended in the RPMI medium as men-
tioned above. After culturing in RPMI 1640 medium containing 40%
fresh autologous serum for 5 days, monocytes di¡erentiated into
monocyte-derived macrophages [13], and then the medium was re-
placed and incubated for another 40 h with or without LPS. The
polynuclear leukocyte fraction, used as granulocytes, was resuspended
in the RPMI medium and cultured in the presence or absence of LPS
for 40 h. IR-AM content of the medium was measured as described
above.
2.7. Statistical analysis
Statistical analysis of the results were performed with one way
analysis of variance (ANOVA), followed by a multiple comparison
test (Fisher’s test). All data were expressed as the mean þ S.E.M. A
level of P6 0.05 was considered to be statistically signi¢cant.
3. Results and discussion
3.1. Production and secretion of immunoreactive AM from
THP-1 and HL-60 cells
The intracellular level of IR-AM was constant and less than
10% of that in culture medium after 40 h incubation in the
absence of stimulants (data not shown). This result indicates
that AM synthesized in THP-1 and HL-60 cells is not stored
in the cells but is secreted constitutively into the medium after
synthesis. Thus, we measured IR-AM content in the culture
medium after 40 h incubation with various substances to eval-
uate AM production in THP-1 and HL-60 cells. The basal
secretion levels of IR-AM from THP-1 and HL-60 cells
were determined to be 0.041 þ 0.005 and 0.056 þ 0.003 fmol/
105 cells/40 h, respectively (Fig. 1), and their secretion levels
were much lower than that from VSMCs and ECs [3^5].
Next, we investigated the e¡ects of substances which acti-
vate or di¡erentiate monocyte/macrophage on IR-AM secre-
tion from THP-1 and HL-60 cells [9]. The secretion rate of
IR-AM from THP-1 and HL-60 cells stimulated with TPA
(1038 M) increased to 0.452 þ 0.013 and 4.535 þ 0.071 fmol/
105 cells/40 h, respectively. In particular, the secretion rate
from HL-60 cells is comparable to that of cultured VSMCs
[5]. RA and IFN-Q showed no e¡ect on IR-AM secretion from
THP-1 and HL-60 cells (data not shown). LPS increased IR-
AM secretion two-fold (0.130 þ 0.002 fmol/105 cells/40 h) from
HL-60 cells, but not from THP-1 cells. The e¡ects of TNF-K
and IL-1L were also examined, since these substances aug-
mented IR-AM secretion from ECs and VSMCs [4,5]. TNF-
K augmented IR-AM secretion about six-fold from HL-60
cells (0.355 þ 0.015 fmol/105 cells/40 h), but not from THP-1
cells. IL-1L showed no e¡ects on IR-AM secretion from both
cell lines (data not shown).
3.2. IR-AM secretion is correlated with di¡erentiation in
THP-1 and HL-60 cells
THP-1 is a monocytic leukemia cell line and is known to
di¡erentiate into macrophage-like cells, having properties sim-
ilar to native monocyte-derived macrophages, after incubating
with phorbol ester [9]. HL-60 is a promyelocytic leukemia cell
line which also di¡erentiates into the macrophage-like cell
after treatment with phorbol ester [13].
As we have shown that the AM secretion from THP-1 and
HL-60 cells greatly increases after stimulation with phorbol
ester (TPA), the relation between AM production and di¡er-
entiation of the leukemia cell lines was evaluated by measur-
ing the expression of MO-1 antigen under the stimulation of
TPA. MO-1 (CD11b), the complement C3b receptor of mye-
loid cells, is expressed at low levels on myeloblasts, and the
cell surface expression of MO-1 has been reported to increase
dramatically according to monocyte/macrophage or granulo-
cyte di¡erentiation [14,15]. Thus, the percentage of MO-1
positive cells has been known to be usable as a marker of
di¡erentiation. As shown in Fig. 1, the AM secretion was
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Fig. 1. AM secretion and MO-1 expression on THP-1 cells and HL-
60 cells stimulated with TPA. a,b: Time course of AM secretion
and MO-1 expression on THP-1 cells (a) and HL-60 cells (b) stimu-
lated with 1038 M of TPA for 0^72 h. c,d: Dose response of AM
secretion and MO-1 expression on THP-1 cells (c) and HL-60 cells
(d) stimulated for 40 h with TPA at increasing doses indicated.
Stippled bar: IR-AM concentration in culture medium of THP-1
cells or HL-60 cells. Closed circle: Positive population of MO-1 ex-
pression. Each point represents the mean þ S.E.M. of four separate
dishes. *P6 0.05 vs. control.
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elevated according to the increased expression population of
the MO-1 antigen on THP-1 and HL-60 cells in a time- and
dose-dependent manner. Furthermore, the cells were incu-
bated with TPA (1038 M) for 3 days to evaluate the basal
secretion levels of AM from fully di¡erentiated cells. After
THP-1 cells were fully di¡erentiated, the resulting THP-1 cells
were found to keep secreting IR-AM at a high rate without
TPA stimulation (0.784 þ 0.019 fmol/105 cells/40 h). In con-
trast, dexamethasone (1036 M), which antagonizes di¡erentia-
tion into macrophages [13,16,17], markedly reduced IR-AM
secretion from THP-1 and HL-60 cells stimulated with 1038
M of TPA to 52.4% and 33%, respectively, although dexame-
thasone itself did not alter basal secretion of IR-AM (data not
shown).
These data indicate that the elevated AM production and
secretion from leukemia cell lines is a result of their di¡er-
entiation into macrophage-like cells rather than the direct
e¡ect of TPA on these cell lines.
3.3. Synergistic e¡ects of RA with other stimulants on IR-AM
secretion from THP-1 and HL-60 cells
To evaluate cooperative e¡ects of stimulators, IR-AM con-
tents in the culture medium of THP-1 and HL-60 cells were
measured after 40 h incubation with all possible combinations
of pairs of the six compounds mentioned above. Among them,
RA was shown to elicit synergistic e¡ects on IR-AM secretion
from THP-1 cells when administered with TNF-K, LPS, IFN-
Q or TPA, elevating IR-AM concentrations 3^7-fold compared
with the absence of RA (Fig. 2). The other combinations did
not induce either additive or synergistic e¡ect on AM produc-
tion (data not shown). Synergistic e¡ects of RA with TPA,
IFN-Q and TNF-K have been widely observed not only in
monocytes/macrophages but also in ¢broblasts, thyroid carci-
noma cell lines and breast cancer cell lines [18^20]. Since RA
was shown to di¡erentiate THP-1 cells into cells with macro-
phage-like characteristics that were slightly di¡erent from
those of cells di¡erentiated by TPA stimulation [21], the
THP-1 cells di¡erentiated with RA were deduced to produce
and secrete AM at a higher rate in response to an additional
stimulator.
When RA and TPA are coadministered to THP-1 and HL-
60 cells, IR-AM secretion from these cells was markedly en-
hanced (Fig. 2). RA has also been reported to activate macro-
phages, potentiating phagocytosis and IL-1 activity in macro-
phage cell line, RAW 264.7 [22]. Based on these data, we
deduce that THP-1 and HL-60 cells di¡erentiate into macro-
phage-like cells in the presence of TPA, and that RA further
stimulates AM production and secretion from the resulting
macrophage-like cells.
On the other hand, RA has been reported to di¡erentiated
HL-60 cells into granulocyte-like cells and to increase gene
transcription of cytokines such as IL-1, TNF-K and IL-6
[11]. RA (1036 M) synergistically increased IR-AM secretion
from HL-60 cells when administered with LPS or TNF-K
(Fig. 2). Thus, granulocyte-like cells are thought to have a
potential to produce and secrete AM into the circulating
blood in the case of sepsis.
As for another mechanism for the synergism in AM pro-
duction, coadministration of RA with TPA or IFN-Q are re-
ported to increase the expression retinoid receptors in U937
cells and breast cancer cell lines [20,23]. In the case of neuro-
blastoma cell line, RA has been shown to increase the number
of TNF-K receptor [24]. Based on these results, the synergistic
e¡ects of RA with TPA, IFN-Q and TNF-K are deduced to be
induced in part by mutual augmentation of the receptor ex-
pression, and AM production in THP-1 and HL-60 cells is
also expected to be synergistically increased by the similar
mechanism.
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Fig. 2. E¡ects of coadministration of RA with LPS, IFN-Q, TNF-K
or TPA on AM secretion from THP-1 cells and HL-60 cells. THP-1
cells (upper) and HL-60 cells (lower) were incubated separately for
40 h with LPS (100 ng/ml), IFN-Q (100 ng/ml), TNF-K (10 ng/ml),
or TPA (1038 M) in the absence (¢lled bar) or presence (stippled
bar) of RA (1036 M). Each value represents the mean þ S.E.M. of
four separate dishes. *P6 0.05, compared with IR-AM level in the
absence of RA.
Table 1
AM secretion from peripheral blood granulocytes, lympocytes, monocytes and monocyte-derived macrophages
IR-AM (fmol/105 cells/40 h)
Control LPS 100 ng/ml
Granulocytes 0.118 þ 0.004 0.119 þ 0.015
Lymphocytes 0.158 þ 0.026 0.153 þ 0.009
Monocytes 0.340 þ 0.003* 0.377 þ 0.006
Monocyte-derived macrophages 1.530 þ 0.101** 10.837 þ 0.295***
Peripheral blood granulocytes, lymphocytes, monocytes and monocyte-derived macrophages were cultured in the absence or presence of LPS for 40
h, and the IR-AM content in the culture medium was measured. Each value represents the mean þ S.E.M. of three separate dishes.
*P6 0.05 vs. granulocytes or lymphocytes without LPS. **P6 0.01 vs. monocytes without LPS. ***P6 0.01 vs. monocyte-derived macrophages
without LPS.
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3.4. IR-AM secretion from peripheral blood granulocytes,
lymphocytes, monocytes and monocyte-derived
macrophages
Granulocytes, lymphocytes and monocytes isolated from
peripheral blood of healthy volunteers were also shown to
secrete IR-AM into culture media (Table 1). Monocytes se-
creted IR-AM at a rate more than twice that of granulocytes
or lymphocytes. Since peripheral blood monocytes were di¡er-
entiated into monocyte-derived macrophages after culturing
in the medium containing 40% fresh autologous serum for
5 days [13], we measured IR-AM concentration in the culture
medium from the monocyte-derived macrophages. The mono-
cyte-derived macrophages thus prepared secreted IR-AM at a
rate ¢ve times higher than that of the monocytes, and the AM
secretion was further augmented about seven-fold by LPS
stimulation (Table 1). Thus, AM is found to be produced
and secreted from lymphocytes, granulocytes, monocytes
and monocyte-derived macrophages isolated from peripheral
blood. AM secretion from the monocyte-derived macrophages
are further increased by LPS stimulation as in the cases of
THP-1 and HL-60 cells di¡erentiated by RA stimulation.
3.5. AM increase the scavenger receptor activity on THP-1
cells
Hampton et al. have indicated that macrophage scavenger
receptors scavenge LPS as well as modi¢ed LDL and reduce
LPS in the circulation or tissues [25]. To evaluate the function
of AM in septic pathophysiology, we measured the scavenger
receptor activity by speci¢c receptor-mediated uptake of DiI-
acLDL, a £uorescent-labeled acLDL probe [26]. TPA treat-
ment on THP-1 cells has been shown to increase the scavenger
receptor activity according to their di¡erentiation into macro-
phage-like cells [14,25,27]. We con¢rmed that the scavenger
receptor activity was augmented after 40 h stimulation with
TPA, while LPS signi¢cantly reduced the scavenger receptor
activity (Fig. 3). The scavenger receptor activity on monocyte-
derived macrophages is also reported to be suppressed by LPS
[28]. Mice lacking the scavenger receptor gene are more sus-
ceptible to endotoxin shock, and the serum levels of TNF-K
and IL-6 are higher in mice lacking the scavenger receptor
gene than those in the wild type [29]. These data indicate
that the suppression of scavenger receptor activity by LPS
decreases the clearance of LPS, augments the production of
proin£ammatory cytokines, and decreases the survival rate of
endotoxin shock. Thus, the scavenger receptor activity is one
of the important factor for modulating the severity of sepsis.
As shown in Fig. 3, AM increased the scavenger receptor
activity on THP-1 cells stimulated with TPA or LPS, although
AM itself showed no e¡ect on the activity. These data suggest
the possibility that AM reduces the e¡ect of LPS by increasing
the scavenger receptor activity on monocytes/macrophages.
We have reported that the synthesis and secretion of AM
from VSMCs and ECs are augmented by LPS, TNF-K and
IL-1L [4,5], and that intravenous administration of LPS into
rats markedly increases plasma AM concentration and AM
gene transcription in almost all tissues [6]. Furthermore, the
average concentration of plasma AM in patients with septic
shock has recently been reported to be 45 times higher than
that of healthy volunteers [7]. Based on these data, we have
attributed high plasma AM concentrations in septic shock to
the elevated production of AM in VSMCs and ECs. In this
study, we demonstrated that THP-1 and HL-60 cells produced
and secreted AM according to their di¡erentiation into mac-
rophages. We also showed that LPS and TNF-K signi¢cantly
increased AM production and secretion from HL-60 cells. The
e¡ects of LPS and TNF-K on AM secretion from THP-1 and
HL-60 cells were greatly enhanced in the presence of RA (Fig.
2). Even with monocyte-derived macrophages from peripheral
blood, LPS highly augmented AM secretion (Table 1). Taken
together, these data demonstrate that monocytes/macrophages
are one of the sources of plasma AM especially in the case of
sepsis. In addition, the present study provides evidence that
AM secreted from monocytes/macrophages increases the scav-
enger receptor activity on themselves.
In conclusion, monocytes/macrophages should be recog-
nized as one of the major sources of AM in the circulating
blood, and the secreted AM may participate in the hypoten-
sion as well as regulation of macrophage functions in the
septic pathophysiology.
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